主動脈血管支架市場規模、佔有率及成長分析（按產品、最終用戶和地區）－2025 年至 2032 年產業預測

Aortic Stent Grafts Market Size, Share, and Growth Analysis, By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End User (Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2025-2032

出版日期: 2025年03月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球主動脈血管支架市場規模價值 32 億美元，預計將從 2024 年的 33.5 億美元成長到 2032 年的 48.4 億美元，預測期內（2025-2032 年）的複合年成長率為 4.7%。

全球主動脈血管支架市場預計將顯著成長，這主要是由於心血管疾病的增加和預期壽命的增加導致主動脈瘤盛行率不斷上升。隨著患者和醫療保健提供者越來越傾向於血管內修復而非傳統手術，對恢復更快、不適感更少的微創手術的需求正在急劇上升。這是由於都市化、醫療保健基礎設施的進步以及旨在改進支架設計的持續研究和開發等因素造成的。然而，它面臨的挑戰包括對新的血管內動脈瘤修復（EVAR）治療的認知低、內漏等併發症的風險以及服務不足地區熟練醫務人員的短缺。解決這些障礙是充分發揮市場潛力的關鍵。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Medtronic（Ireland）
WL Gore & Associates, Inc.（USA）
Cook Medical（USA）
Terumo Aortic（Japan）
Endologix LLC（USA）
Jotec（Germany）
MicroPort Scientific Corporation（China）
Corcym（Italy）
Edwards Lifesciences Corporation（USA）
Bentley Healthcare Pvt. Ltd.（India）
Braile Biomedica（Brazil）
Cardinal Health（USA）
InSitu Technologies Inc.（USA）
Artivion Inc.（USA）
Cryolife Inc.（USA）
Lombard Medical Inc.（UK）
Bolton Medical（Spain）

結論和建議

簡介目錄

Product Code: SQMIG35B2078

Global Aortic Stent Grafts Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.35 billion in 2024 to USD 4.84 billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

The global aortic stent graft market is poised for notable growth, primarily driven by an increasing prevalence of aortic aneurysms linked to rising cardiovascular diseases and longer life expectancies. As patients and healthcare providers favor endovascular repairs over traditional surgeries, there is a surge in demand for minimally invasive procedures that offer quicker recovery times and reduced discomfort. Contributing factors include urbanization, advancements in healthcare infrastructure, and ongoing research and development targeting improved stent designs. However, market growth faces challenges such as limited awareness of new endovascular aneurysm repair (EVAR) treatments, risks of complications like endoleaks, and a shortage of skilled medical professionals in underserved regions. Addressing these hurdles will be critical for maximizing the market's potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Stent Grafts Market Segments Analysis

Global Aortic Stent Grafts Market is segmented by Product, End User and region. Based on Product, the market is segmented into Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Stent Grafts Market

The global aortic stent grafts market is expected to experience significant growth throughout the forecast period, driven by several key factors. The preference for endovascular repair techniques over traditional open surgical methods is gaining momentum, alongside rising life expectancy rates. Additionally, the increasing adoption of minimally invasive surgical procedures contributes to this trend. The surge in clinical trials and FDA approvals aimed at developing innovative aortic stent graft designs further propels market expansion. As these elements align, they collectively enhance the demand for aortic stent grafts, positioning the market for promising advancements and opportunities in the years ahead.

Restraints in the Global Aortic Stent Grafts Market

However, the growth of the Global Aortic Stent Grafts market may be hindered by several factors, including a shortage of properly trained healthcare professionals and insufficient knowledge regarding the new Endovascular Aneurysm Repair (EVAR) techniques. Additionally, concerns about potential complications, such as endoleaks and other risks associated with aortic stent grafts, could further limit market development during the forecast period. These challenges may impact the adoption and implementation of advanced treatments in various healthcare settings, ultimately affecting the overall market dynamics for aortic stent grafts.

Market Trends of the Global Aortic Stent Grafts Market

The Global Aortic Stent Grafts market is poised for significant growth from 2023 to 2030, driven by an ageing demographic and a rising incidence of aortic aneurysms. As the prevalence of cardiovascular diseases increases, coupled with heightened awareness regarding stenting and grafting technologies, demand for these medical devices is expected to burgeon. Additionally, the landscape is being positively influenced by a surge in regulatory approvals and rapid advancements in medical technology, which enhance the efficacy and safety of stent grafts. Collectively, these factors are shaping a robust market trend, positioning aortic stent grafts as critical components in cardiovascular healthcare solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Aortic Stent Grafts Market Size by Product & CAGR (2025-2032)

Market Overview
Abdominal Aortic Stent Graft
Thoracic Aortic Stent Graft

Global Aortic Stent Grafts Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgical Centers

Global Aortic Stent Grafts Market Size & CAGR (2025-2032)

North America (Product, End User)
- US
- Canada
Europe (Product, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Aortic (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corcym (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bentley Healthcare Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braile Biomedica (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSitu Technologies Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artivion Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolife Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical Inc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bolton Medical (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments